contact
Mocholi Industrial Estate, Plaza Cein 5,
31110 Noáin, Navarre (Spain)
31110 Noáin, Navarre (Spain)
Shaping the future of ingredients!
News & Projects
Call of the Extraordinary General Shareholders Meeting – July 2026
MOA Biotech, S.L. hereby convenes its shareholders to the Extraordinary General Meeting to be held on July 21, 2026, at 10:00 AM CEST at the company's registered office and via Microsoft Teams.
The agenda will include the review and approval of the 2025 annual accounts, proposals for share capital increases, and updates to the company's by-laws.
Shareholders may request all relevant documentation free of charge or notify their attendance by videoconference until July 20, 2026.
read full report
read full report
%201.png)
MOA Foodtech, seleccionada por el Gobierno de Navarra en las ayudas a la competitividad 2025
MOA Biotech, S.L. hereby convenes its shareholders to the Extraordinary General Meeting to be held on July 21, 2026, at 10:00 AM CEST at the company's registered office and via Microsoft Teams.
The agenda will include the review and approval of the 2025 annual accounts, proposals for share capital increases, and updates to the company's by-laws.
Shareholders may request all relevant documentation free of charge or notify their attendance by videoconference until July 20, 2026.
MOA Foodtech ha sido beneficiaria de una subvención del Gobierno de Navarra dentro de la convocatoria de ayudas para la mejora de la competitividad 2025. Un respaldo que refuerza nuestra capacidad para seguir desarrollando tecnología de fermentación aplicada a la industria alimentaria.
read full report
read full report
PERTE – ACCELEREAT
MOA Biotech, S.L. hereby convenes its shareholders to the Extraordinary General Meeting to be held on July 21, 2026, at 10:00 AM CEST at the company's registered office and via Microsoft Teams.
The agenda will include the review and approval of the 2025 annual accounts, proposals for share capital increases, and updates to the company's by-laws.
Shareholders may request all relevant documentation free of charge or notify their attendance by videoconference until July 20, 2026.
Actuaciones de fortalecimiento industrial del sector agroalimentario dentro del Proyecto Estratégico para la Recuperación y Transformación Económica Agroalimentario, en el marco del Plan de Recuperación, Transformación y Resiliencia, financiado por la Unión Europea - NextGenerationEU
read full report
read full report
PROMISEANG (Horizon Europe)
MOA Biotech, S.L. hereby convenes its shareholders to the Extraordinary General Meeting to be held on July 21, 2026, at 10:00 AM CEST at the company's registered office and via Microsoft Teams.
The agenda will include the review and approval of the 2025 annual accounts, proposals for share capital increases, and updates to the company's by-laws.
Shareholders may request all relevant documentation free of charge or notify their attendance by videoconference until July 20, 2026.
PROMISEANG seeks to produce innovative proteins from underused marine resources and industrial by-products through microbial fermentation, creating biomass suitable for food, feed, and non-food applications like pharmaceuticals and cosmetics.
read full report
read full report
VALSANA (Gobierno de Navarra)
MOA Biotech, S.L. hereby convenes its shareholders to the Extraordinary General Meeting to be held on July 21, 2026, at 10:00 AM CEST at the company's registered office and via Microsoft Teams.
The agenda will include the review and approval of the 2025 annual accounts, proposals for share capital increases, and updates to the company's by-laws.
Shareholders may request all relevant documentation free of charge or notify their attendance by videoconference until July 20, 2026.
Moa Biotech has received a grantco-financed by the EuropeanRegional Development Fundthrough the FEDER OperationalProgram 2014-2020 of Navarra. The project aims to develop a bioeconomy through green chemistry and biotechnology by converting industrial and agro-food byproducts into value-added products such as biofuels, fertilizers, antioxidants, antimicrobials, proteins, biostimulants, and biomaterials, with applications in energy, health, and sustainable food systems.
read full report
read full report
NEWPROTEIN (CDTI)
MOA Biotech, S.L. hereby convenes its shareholders to the Extraordinary General Meeting to be held on July 21, 2026, at 10:00 AM CEST at the company's registered office and via Microsoft Teams.
The agenda will include the review and approval of the 2025 annual accounts, proposals for share capital increases, and updates to the company's by-laws.
Shareholders may request all relevant documentation free of charge or notify their attendance by videoconference until July 20, 2026.
Valorización de subproductos de la industria cárnica mediante fermentación para la elaboración de nuevos productos curados y cocidos (Newprotein).
(IDI-20221119) en cooperación con el Departamento de I+D+i del GrupoIncarlopsa.
read full report
read full report
NEOTEC
MOA Biotech, S.L. hereby convenes its shareholders to the Extraordinary General Meeting to be held on July 21, 2026, at 10:00 AM CEST at the company's registered office and via Microsoft Teams.
The agenda will include the review and approval of the 2025 annual accounts, proposals for share capital increases, and updates to the company's by-laws.
Shareholders may request all relevant documentation free of charge or notify their attendance by videoconference until July 20, 2026.
DESARROLLO DE INGREDIENTES SOSTENIBLES Y DE ALTO VALOR AÑADIDO A TRAVÉS DE LA REVALORIZACIÓN DE SUBPRODUCTOS ALIMENTARIOS, BASADO EN BIOTECNOLOGÍA E IA
PROYECTO FINANCIADO POR EL PROGRAMA NEOTEC 2023
para el apoyo a la creación y consolidación de empresas de base tecnológica
Nº Ref. SNEO-20231300
read full report
read full report
EIC Accelerator
MOA Biotech, S.L. hereby convenes its shareholders to the Extraordinary General Meeting to be held on July 21, 2026, at 10:00 AM CEST at the company's registered office and via Microsoft Teams.
The agenda will include the review and approval of the 2025 annual accounts, proposals for share capital increases, and updates to the company's by-laws.
Shareholders may request all relevant documentation free of charge or notify their attendance by videoconference until July 20, 2026.
EIC Accelerator supports innovative SMEs with disruptive technologies or business models, strong scale-up potential, and high-risk projects that require significant public funding beyond what private investors can provide.
read full report
read full report
